Sho Sato

594 citations
32 papers · 411 indexed · h-index 12
Topics
Ovarian cancer diagnosis and treatment (9 papers)Immune Cell Function and Interaction (5 papers)Endometrial and Cervical Cancer Treatments (4 papers)

In The Last Decade

Sho Sato

27 papers receiving 408 citations

Peers

Sho Sato
Comparison fields: 5 of 47
  • Oncology 157
  • Reproductive Medicine 132
  • Molecular Biology 117
  • Obstetrics and Gynecology 116
  • Immunology 101
Replace Apostolos C Ziogas with:
Apostolos C Ziogas Greece
D-S Bae South Korea
Omer Devaja United Kingdom
Eva Glud Denmark
A.M. Newtson United States
Gonzalo Giornelli Argentina
Shiro Takamatsu Japan
Yuichi Imai Japan
Mark A. Glaire United Kingdom
Sho Sato relative to Apostolos C Ziogas Greece Apostolos C Ziogas's profile →
Citations per field
00.5×2.6×
Apostolos C Ziogas · 1×
Citations per year

Countries citing papers authored by Sho Sato

Since Specialization
Citations

This map shows the geographic impact of Sho Sato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sho Sato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sho Sato more than expected).

Fields of papers citing papers by Sho Sato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sho Sato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sho Sato. The network helps show where Sho Sato may publish in the future.

Co-authorship network of co-authors of Sho Sato

This figure shows the co-authorship network connecting the top 25 collaborators of Sho Sato. A scholar is included among the top collaborators of Sho Sato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sho Sato. Sho Sato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 0
5 6
6 10
7 1
8 14
9 5
10 10
11 11
12 30
13 20
14 34
15 8
16 22
17 8
18 39
19 57
20
117 Experimental growth retardation in the fetal rat.
3

About Sho Sato

Sho Sato is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 32 papers that have together received 411 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (9 papers), Immune Cell Function and Interaction (5 papers) and Endometrial and Cervical Cancer Treatments (4 papers). The work is most often cited by research in Reproductive Medicine (132 citations), Obstetrics and Gynecology (116 citations) and Oncology (157 citations). Sho Sato has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Kosei Hasegawa, Keiichi Fujiwara, Hiroyuki Seki, Kazunori Baba, Tomonori Nagai, Takahiro Uotani, Shigetaka Matsunaga, Hiroaki Ishida, Yasushi Takai and Yuji Ikeda. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026